We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+22.56%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$5.84M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.09M |
| 2 |
PayPal
PYPL
|
+$4.84M |
| 3 |
STAAR Surgical
STAA
|
+$3.72M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$3.18M |
| 5 |
Microsoft
MSFT
|
+$2.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$7.85M |
| 2 |
iQIYI
IQ
|
+$7.2M |
| 3 |
ON Semiconductor
ON
|
+$4.1M |
| 4 |
Apple
AAPL
|
+$2.75M |
| 5 |
uniQure
QURE
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Axsome Therapeutics
AXSM
$11.2B
| $36.3K | 0.01% |
589
+148
| +34% | +$9.72K |
|
|
RVNC
177
DELISTED
Revance Therapeutics, Inc.
RVNC
| $36.1K | 0.01% |
1,122
+286
| +34% | +$8.91K |
|
178
Prothena Corp
PRTA
$475M
| $34.5K | 0.01% |
712
+221
| +45% | +$11.7K |
|
179
BridgeBio Pharma
BBIO
$16.4B
| $34K | 0.01% |
2,050
+531
| +35% | +$6.19K |
|
|
SAGE
180
DELISTED
Sage Therapeutics
SAGE
| $33.9K | 0.01% |
809
+204
| +34% | +$8.77K |
|
181
Insmed
INSM
$28.9B
| $31.5K | 0.01% |
1,848
+472
| +34% | +$9.17K |
|
182
Applied Materials
AMAT
$435B
| $31.4K | 0.01% |
+256
| New | +$29.4K |
|
183
Zai Lab
ZLAB
$2.86B
| $31.4K | 0.01% |
945
+244
| +35% | +$9.36K |
|
184
Xenon Pharmaceuticals
XENE
$6.31B
| $30.4K | 0.01% |
848
+213
| +34% | +$7.87K |
|
185
AbCellera Biologics
ABCL
$3.18B
| $29.4K | 0.01% |
3,898
+992
| +34% | +$9.01K |
|
|
MRTX
186
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $29.2K | 0.01% |
786
+201
| +34% | +$9.04K |
|
187
Mondelez International
MDLZ
$79.4B
| $28.7K | 0.01% |
+412
| New | +$27.3K |
|
|
PRVB
188
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $28.5K | 0.01% |
1,181
+295
| +33% | +$3.7K |
|
189
Krystal Biotech
KRYS
$9.85B
| $27.9K | 0.01% |
349
+87
| +33% | +$6.83K |
|
190
Automatic Data Processing
ADP
$107B
| $27.8K | 0.01% |
+125
| New | +$28.2K |
|
191
Immunovant
IMVT
$8.8B
| $27.4K | 0.01% |
1,764
+452
| +34% | +$7.84K |
|
192
Relay Therapeutics
RLAY
$4.4B
| $27.1K | 0.01% |
1,644
+416
| +34% | +$7.46K |
|
193
Supernus Pharmaceuticals
SUPN
$2.78B
| $26.6K | 0.01% |
733
+184
| +34% | +$7.08K |
|
194
Revolution Medicines
RVMD
$44B
| $26.6K | 0.01% |
1,226
+324
| +36% | +$7.98K |
|
195
Harmony Biosciences
HRMY
$2.32B
| $26.3K | 0.01% |
807
+204
| +34% | +$9.29K |
|
196
Amylyx Pharmaceuticals
AMLX
$2.6B
| $26.3K | 0.01% |
897
+224
| +33% | +$7.78K |
|
|
VTYX
197
DELISTED
Ventyx Biosciences
VTYX
| $25.7K | 0.01% |
767
+192
| +33% | +$7.47K |
|
198
Myriad Genetics
MYGN
$309M
| $25.5K | 0.01% |
1,098
+275
| +33% | +$5.58K |
|
199
Pacira BioSciences
PCRX
$945M
| $25.4K | 0.01% |
623
+157
| +34% | +$6.25K |
|
200
Maravai LifeSciences
MRVI
$861M
| $25K | 0.01% |
1,786
+450
| +34% | +$6.46K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q1 2023 Portfolio in Review
As of Q1 2023, China Universal Asset Management Company held 456 positions worth $295M, up 19% from $249M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
China Universal Asset Management Company's Q1 2023 filing shows 65 new, 317 increased, 38 reduced and 9 closed positions. Its largest new stake was Baidu: 20,500 shares worth $3.09M. The largest sale was Pinduoduo, an estimated $7.85M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q1 2023 buy was Baidu: 20,500 shares worth $3.09M.
- China Universal Asset Management Company added most to NVIDIA in Q1 2023, an estimated $6.09M increase.
- China Universal Asset Management Company's biggest Q1 2023 reduction was Pinduoduo, cutting an estimated $7.85M.
- China Universal Asset Management Company fully exited Tower Semiconductor in Q1 2023, selling an estimated $1.94M.
- China Universal Asset Management Company's ten largest holdings make up 32% of its $295M portfolio in Q1 2023.
- China Universal Asset Management Company opened 65 new positions and closed 9 in Q1 2023.
- China Universal Asset Management Company's portfolio value rose 19% quarter-over-quarter to $295M.
Based on China Universal Asset Management Company's 13F filing for Q1 2023, filed 28 Apr 2023.